Algunos de estas aportaciones desde una perspectiva de complejidad las encontramos en:
ESTRATEGIAS, RECURSOS
6.4 Creatividad centrada desde el docente
1
Abbas S., Linseisen J., Rohrmann S., Chang-Claude J., Peeters P.H., Engel P., Brustad M., Lund E., Skeie G., Olsen A., Tjønneland A., Overvad K., Boutron- Ruault M.-C., Clavel-Chapelon F., Fagherazzi G., Kaaks R., Boeing H., Buijsse B., Adarakis G., Ouranos V., Trichopoulou A., Masala G., Krogh V., Mattiello A., Tumino R., Sacerdote C., Buckland G., Suárez M.V.A., Sánchez M.-J., Chirlaque M.-D., Barricarte A., Amiano P., Manjer J., Wirfält E., Lenner P., Sund M., Bueno-De-Mesquita H.B., Van Duijnhoven F.J.B., Khaw K.-T., et al.Dietary intake of vitamin D and calcium and breast cancer risk in the European prospective investigation into cancer and nutrition.
Nutr Cancer 2013; 65: 178-187
[IF 2.695]
2
Adamo M.S., Alessi D., Aletta P., Amodio R., Andreone S., Angelin T., Anghinoni E., Annulli M.L., Antonini S., Artioli M.E., Autelitano M., Balducci C., Balottari P., Baracco M., Battisti W., Bella F., Bellatalla C., Belluardo C., Benatti P., Benedetto G., Benfatto L., Bernazza E., Bianconi F., Biavati P., Bidoli E., Birri S., Bizzoco S., Bonelli L., Bonini A., Borciani E., Bovo E., Bozzani F., Bozzeda A., Braghiroli B., Brucculeri M.A., Brunori V., Bucalo G., Bucchi L., Bugliarello E., et al.Italian cancer figures, report 2013: Multiple tumours.
Epidemiol Prev 2013; 37: 1-152
[IF 0.919]
3
Agnoli C., Grioni S., Sieri S., Palli D., Masala G., Sacerdote C., Vineis P., Tumino R., Giurdanella M.C., Pala M.V., Berrino F., Mattiello A., Panico S., Krogh V.Italian mediterranean index and risk of colorectal cancer in the Italian section of the EPIC cohort.
Int J Cancer 2013; 132: 1404-1411
[IF 6.198]
4
Agresti R., Trecate G., Ferraris C., Valeri B., Maugeri I., Pellitteri C., Martelli G., Migliavacca S., Carcangiu M.L., Bohm S., Maffioli L., Vergnaghi D., Panizza P.Ex vivo MRI evaluation of breast tumors: A novel tool for verifying resection of nonpalpable only MRI detected lesions.
Breast J 2013; 19: 659-663
[IF 1.831]
5
Agudo A., Bonet C., Sala N., Muñoz X., Aranda N., Fonseca-Nunes A., Clavel-Chapelon F., Boutron- Ruault M.C., Vineis P., Panico S., Palli D., Tumino R., Grioni S., Ramón Quirós J., Molina E., Navarro C., Barricarte A., Chamosa S., Allen N.E., Khaw K.-T., Bas Bueno-de-Mesquita H., Siersema P.D., Numans M.E., Trichopoulou A., Lagiou P., Trichopoulos D., Kaaks R., Canzian F., Boeing H., Meidtner K., Johansson M., Sund M., Manjer J., Overvad K., Tjonneland A., Lund E., Weiderpass E., Jenab M., Fedirko V., et al.Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the european prospective investigation into cancer and nutrition (EPIC) study.
Carcinogenesis 2013; 34: 1244-1250
[IF 5.635]
6
Aktolun C., Castellani M.R., Bombardieri E. Diagnostic and therapeutic use of MIBG in pheochromocytoma and paraganglioma.Q J Nucl Med Mol Imaging 2013; 57: 109-111
[IF 1.918]
7
Aktolun C., Castellani M.R. Theranostic role of MIBG in neuroblastoma.Q J Nucl Med Mol Imaging 2013; 57: 3-5
[IF 1.918]
8
Alaggio R., Turrini R., Boldrin D., Merlo A., Gambini C., Ferrari A., Dall’igna P., Coffin C.M., Martines A., Bonaldi L., De Salvo G.L., Zanovello P., Rosato A.Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).
PLoS ONE 2013; 8: e80456
N°
Authors
Title
Journal
IF
9
Aleksandrova K., Pischon T., Buijsse B., May A.M., Peeters P.H., Bueno-De-Mesquita H.B., Jenab M., Fedirko V., Dahm C.C., Siersema P.D., Freisling H., Ferrari P., Overvad K., Tjønneland A., Trichopoulou A., Lagiou P., Naska A., Pala M.V., Mattiello A., Ohlsson B., Jirström K., Key T.J., Khaw K.-T., Riboli E., Boeing H.Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
Eur J Cancer 2013; 49: 3526-3536
[IF 5.061]
10
Al-Jumaily U., Ayyad O., Masarweh M., Ghandour K., Almousa A., Al-Hussaini M., Ferrari A., Sultan I.Improved care of rhabdomyosarcoma in Jordan using less intensive therapy.
Pediatr Blood Cancer 2013; 60: 53-58
[IF 2.353]
11
Allemani C., Minicozzi P., Berrino F., Bastiaannet E., Gavin A., Galceran J., Ameijide A., Siesling S., Mangone L., Ardanaz E., Hédelin G., Mateos A., Micheli A., Sant M.Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002.
Int J Cancer 2013; 132: 2404-2412
[IF 6.198]
12
Allemani C., Rachet B., Weir H.K., Richardson L.C., Lepage C., Faivre J., Gatta G., Capocaccia R., Sant M., Baili P., Lombardo C., Aareleid T., Ardanaz E., Bielska-Lasota M., Bolick S., Cress R., Elferink M., Fulton J.P., Galceran J., Gózdz S., Hakulinen T., Primic-Žakelj M., Rachtan J., Diba C.S., Sánchez M.-J., Schymura M.J., Shen T., Tagliabue G., Tumino R., Vercelli M., Wolf H.J., Wu X.-C., Coleman M.P.Colorectal cancer survival in the USA and Europe: A CONCORD high- resolution study.
BMJ Open 2013; 3: e003055
[IF 1.583]
13
Allemani C., Sant M., Weir H.K., Richardson L.C., Baili P., Storm H., Siesling S., Torrella-Ramos A., Voogd A.C., Aareleid T., Ardanaz E., Berrino F., Bielska-Lasota M., Bolick S., Cirilli C., Colonna M., Contiero P., Cress R., Crocetti E., Fulton J.P., Grosclaude P., Hakulinen T., Izarzugaza M.I., Malmström P., Peignaux K., Primic-Žakelj M., Rachtan J., Safaei Diba C., Sánchez M.-J., Schymura M.J., Shen T., Traina A., Tryggvadottir L., Tumino R., Velten M., Vercelli M., Wolf H.J., Woronoff A.-S., Wu X., et al.Breast cancer survival in the US and Europe: A CONCORD high-resolution study.
Int J Cancer 2013; 132: 1170-1181
[IF 6.198]
14
Allen N.E., Appleby P.N., Key T.J., Bueno-De- Mesquita H.B., Ros M.M., Kiemeney L.A.L.M., Tjønneland A., Roswall N., Overvad K., Weikert S., Boeing H., Chang-Claude J., Teucher B., Panico S., Sacerdote C., Tumino R., Palli D., Sieri S., Peeters P., Quirós J.R., Jakszyn P., Molina-Montes E., Chirlaque M.-D., Ardanaz E., Dorronsoro M., Khaw K.-T., Wareham N., Ljungberg B., Hallmans G., Ehrnström R., Ericson U., Gram I.T., Parr C.L., Trichopoulou A., Karapetyan T., Dilis V., Clavel- Chapelon F., Boutron-Ruault M.-C., Fagherrazzi G., et al.Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
Int J Cancer 2013; 132: 635-644
[IF 6.198]
15
Amadori D., Aglietta M., Alessi B., Gianni L., Ibrahim T., Farina G., Gaion F., Bertoldo F., Santini D., Rondena R., Bogani P., Ripamonti C.I.Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): A phase 3, open-label, randomised, non-inferiority trial.
Lancet Oncol 2013; 14: 663-670
[IF 25.117]
16
Amadori D., Mercatali L., Nanni O., Aglietta M., Alessi B., Gianni L., Farina G., Gaion F., Bertoldo F., Santini D., Rondena R., Bogani P., Ripamonti C.B., Ibrahim T.What can we learn from the zoom trial? - Authors’ reply.
Lancet Oncol 2013; 14: e388-e390
[IF 25.117]
17
Anania M.C., Miranda C., Vizioli M.G., Mazzoni M., Cleris L., Pagliardini S., Manenti G., Borrello M.G., Pierotti M.A., Greco A.S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma.
J Clin Endocrinol Metab 2013; 98: E1591-E1600
N°
Authors
Title
Journal
IF
18
Andriani F., Facchinetti F., Furia S., Roz L., Bursomanno S., Bertolini G., Carniti C., Sozzi G., Pastorino U.Adipose tissue displays trophic properties on normal lung cellular components without promoting cancer cells growth.
J Cell Physiol 2013; 228: 1166-1173
[IF 4.218]
19
Angelico M., Nardi A., Marianelli T., Caccamo L., Romagnoli R., Tisone G., Pinna A.D., Avolio A.W., Fagiuoli S., Burra P., Strazzabosco M., Costa A.N., Angelico M., Cillo U., Fagiuoli S., Strazzabosco M., Caraceni P., Toniutto P.L., Costa A., Salizzoni M., Romagnoli R., Bertolotti G., Patrono D., De Carlis L., Slim A., Mangoni J.M., Rossi G., Caccamo L., Antonelli B., Mazzaferro V., Regalia E., Sposito C., Colledan M., Corno V., Tagliabue F., Marin S., Cillo U., Vitale A., Gringeri E., et al.Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
J Hepatol 2013; 58: 715-723
[IF 9.858]
20
Angelini S., Pantaleo M.A., Ravegnini G., Zenesini C., Cavrini G., Nannini M., Fumagalli E., Palassini E., Saponara M., Di Battista M., Casali P.G., Hrelia P., Cantelli-Forti G., Biasco G.Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy.
Pharmacol Res 2013; 68: 1-6
[IF 4.346]
21
Antelmi E., Cardone R.A., Greco M.R., Rubino R., Di Sole F., Martino N.A., Casavola V., Carcangiu M.L., Moro L., Reshkin S.J.ß1 Integrin Binding Phosphorylates Ezrin at T567 to Activate a Lipid Raft Signalsome Driving Invadopodia Activity and Invasion.
PLoS ONE 2013; 8: e75113
[IF 3.73]
22
Aredia F., Giansanti V., Mazzini G., Savio M., Ortiz L.M.G., Jaadane I., Zaffaroni N., Forlino A., Torriglia A., Scovassi A.I.Multiple effects of the Na+/H+ antiporter inhibitor HMA on cancer cells.
Apoptosis 2013; 18: 1586-1598
[IF 3.949]
23
Ascierto P.A., Grimaldi A.M., Acquavella N., Borgognoni L., Calabrò L., Cascinelli N., Cesano A., Del Vecchio M., Eggermont A.M., Faries M., Ferrone S., Fox B.A., Gajewski T.F., Galon J., Gnjatic S., Gogas H., Kashani-Sabet M., Kaufman H.L., Larkin J., Lo R.S., Mantovani A., Margolin K., Melief C., McArthur G., Palmieri G., Puzanov I., Ribas A., Seliger B., Sosman J., Suenaert P., Tarhini A.A., Trinchieri G., Vidal-Vanaclocha F., Wang E., Ciliberto G., Mozzillo N., Marincola F.M., Thurin M.Future perspectives in melanoma research. Meeting report from the Melanoma Bridge. Napoli, December 2nd-4th 2012”.
J Transl Med 2013; 11: 137
[IF 3.459]
24
Azim H.A. Jr, Agbor-Tarh D., Bradbury I., Dinh P., Baselga J., Di Cosimo S., Greger J.G. Jr, Smith I., Jackisch C., Kim S.B., Aktas B., Huang C.S., Vuylsteke P., Hsieh R.K., Dreosti L., Eidtmann H., Piccart M., de Azambuja E.Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial.
J Clin Oncol 2013; 31: 4504-4511
[IF 18.038]
25
Azim H.A., Rothé F., Aura C.M., Bavington M., Maetens M., Rouas G., Gebhart G., Gamez C., Eidtmann H., Baselga J., Piccart-Gebhart M., Ellis C., Vuylsteke P., Cure H., Domont J., Ferro A., Toral-Peña J.C., de Azambuja E., Sotiriou C., Di Cosimo S., Ignatiadis M.Circulating tumor cells and response to neoadjuvant paclitaxel and HER2- targeted therapy: A sub-study from the NeoALTTO phase III trial.
Breast 2013; 22: 1060-1065
[IF 1.967]
26
Bagnoli M., Beretta G.L., Gatti L., Pilotti S., Alberti P., Tarantino E., Barbareschi M., Canevari S., Mezzanzanica D., Perego P.Clinicopathological impact of ABCC1/ MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma.
Biomed Res Int 2013; 2013: 143202
27
Baili P., Hoekstra-Weebers J., Van Hoof E., Bartsch H.H., Travado L., Garami M., Di Salvo F., Micheli A., Veerus P.Cancer rehabilitation indicators for Europe.
Eur J Cancer 2013; 49: 1356-1364
N°
Authors
Title
Journal
IF
28
Baili P., Vicentini M., Tumino R., Vercelli M., Lorenzo M., Foschi R., Guzzinati S., Dal Maso L., Minicozzi P., De Lorenzo F., Micheli A., Di Salvo F., CAREMORE GROUP, Gatta G., Trama A.A method for differentiating cancer prevalence according to health status, exemplified using a population-based sample of Italian colorectal cancer cases.
Acta Oncol 2013; 52: 294-302
[IF 2.867]
29
Bakrin N., Gilly F.N., Baratti D., Bereder J.M., Quenet F., Lorimier G., Mohamed F., Elias D., Glehen O.Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi- institutional study of 36 patients.
EJSO-EUR J SURG ONC 2013; 39: 742-747
[IF 2.614]
30
Baldi G.G., Stacchiotti S., Mauro V., Dei Tos A.P., Gronchi A., Pastorino U., Duranti L., Provenzano S., Marrari A., Libertini M., Pilotti S., Casali P.G.Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients.
Clin Sarcoma Res 2013; 3: 4
31
Baltar V.T., Xun W.W., Johansson M., Ferrari P., Chuang S.-C., Relton C., Ueland P.M., Midttun O., Slimani N., Jenab M., Clavel-Chapelon F., Boutron- Ruault M.-C., Fagherazzi G., Kaaks R., Rohrmann S., Boeing H., Weikert C., Bueno-De-Mesquita B., Boshuizen H., Van Gils C.H., Onland-Moret N.C., Agudo A., Barricarte A., Navarro C., Rodríguez L., Castaño J.M.H., Larrañaga N., Khaw K.-T., Wareham N., Allen N.E., Crowe F., Gallo V., Norat T., Krogh V., Masala G., Panico S., Sacerdote C., Tumino R., Trichopoulou A., et al.A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk.
Eur J Epidemiol 2013; 28: 677-688
[IF 5.118]
32
Bamia C., Lagiou P., Buckland G., Grioni S., Agnoli C., Taylor A.J., Dahm C.C., Overvad K., Olsen A., Tjønneland A., Cottet V., Boutron-Ruault M.-C., Morois S., Grote V., Teucher B., Boeing H., Buijsse B., Trichopoulos D., Adarakis G., Tumino R., Naccarati A., Panico S., Palli D., Bueno-De- Mesquita H.B., Van Duijnhoven F.J.B., Peeters P.H.M., Engeset D., Skeie G., Lund E., Sánchez M.-J., Barricarte A., Huerta J.-M., Quirós J.R., Dorronsoro M., Ljuslinder I., Palmqvist R., Drake I., Key T.J., Khaw K.-T., et al.Mediterranean diet and colorectal cancer risk: Results from a European cohort.
Eur J Epidemiol 2013; 28: 317-328
[IF 5.118]
33
Bampo C., Alessi A., Fantini S., Bertarelli G., De Braud F., Bombardieri E., Valvo F., Crippa F., Di Bartolomeo M., Mariani L., Milione M., Biondani P., Avuzzi B., Chiruzzi C., Pietrantonio F.Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?.
Oncology 2013; 84: 191-199
[IF 2.165]
34
Bangma C.H., Bul M., van der Kwast T.H., Pickles T., Korfage I.J., Hoeks C.M., Steyerberg E.W., Jenster G., Kattan M.W., Bellardita L., Carroll P.R., Denis L.J., Parker C., Roobol M.J., Emberton M., Klotz L.H., Rannikko A., Kakehi Y., Lane J.A., Schröder F.H., Semjonow A., Trock B.J., Valdagni R.Active surveillance for low-risk prostate cancer.
Crit Rev Oncol Hematol 2013; 85: 295-302
[IF 4.637]
35
Baratti D., Kusamura S., Cabras A.D., Bertulli R., Hutanu I., Deraco M.Diffuse malignant peritoneal mesothelioma: Long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Eur J Cancer 2013; 49: 3140-3148
[IF 5.061]
36
Bassoli S., Maurichi A., Rodolfo M., Casari A., Frigerio S., Pupelli G., Farnetani F., Pelosi G., Santinami M., Pellacani G.CDKN2A and MC1R variants influence dermoscopic and confocal features of benign melanocytic lesions in multiple melanoma patients.
Exp Dermatol 2013; 22: 411-416
N°
Authors
Title
Journal
IF
37
Belardi V., Fiore E., Giustarini E., Muller I., Sabatini S., Rosellini V., Seregni E., Agresti R., Marcocci C., Vitti P., Giani C.Is the risk of primary
hyperparathyroidismincreased in patients with untreated breast cancer?.
J Endocrinol Invest 2013; 36: 321-325
[IF 1.654]
38
Bella F., Minicozzi P., Giacomin A., Crocetti E., Federico M., Ponz De Leon M., Fusco M., Tumino R., Mangone L., Giuliani O., Budroni M., Sant M.Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients.
J Cancer Res Clin Oncol 2013; 139: 1303-1310
[IF 2.914]
39
Bellardita L., Rancati T., Alvisi M.F., Villani D., Magnani T., Marenghi C., Nicolai N., Procopio G., Villa S., Salvioni R., Valdagni R.Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance.
Eur Urol 2013; 64: 30-36
[IF 10.476]
40
Bellardita L., Valdagni R., Rancati T. Reply from Authors re: Laurence Klotz. Active surveillance, quality of life, and cancer-related anxiety. Eur Urol 2013;64:37-9: Active surveillance: Risk and protective factors for quality of life.Eur Urol 2013; 64: 39-40
[IF 10.476]
41
Bellone M., Calcinotto A., Filipazzi P., De Milito A., Fais S., Rivoltini L.The acidity of the tumor
microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.
Oncoimmunology 2013; 2: e22058
42
Belloni E., Panizza P., Ravelli S., De Cobelli F., Gusmini S., Losio C., Sassi I., Perseghin G., Del Maschio A.MR-guided stereotactic breast biopsy using a mixed ferromagnetic- nonmagnetic coaxial system with 12- to 18-gauge needles: Clinical experience and long-term outcome.
Radiol Med 2013; 118: 1137-1148
[IF 1.461]
43
Bel-Serrat S., Mouratidou T., Börnhorst C., Peplies J., De Henauw S., Marild S., Molnár D., Siani A., Tornaritis M., Veidebaum T., Krogh V., A. Moreno L.Food consumption and cardiovascular risk factors in European children: The IDEFICS study.
Pediatr Obes 2013; 8: 225-236
44
Bel-Serrat S., Mouratidou T., Santaliestra-Pasías A.M., Iacoviello L., Kourides Y.A., Marild S., Molnár D., Reisch L., Siani A., Stomfai S., Vanaelst B., Veidebaum T., Pigeot I., Ahrens W., Krogh V., Moreno L.A.Clustering of multiple lifestyle behaviours and its association to cardiovascular risk factors in children: The IDEFICS study.
Eur J Clin Nutr 2013; 67: 848-854
[IF 2.756]
45
Bendinelli B., Palli D., Masala G., Sharp S.J., Schulze M.B., Guevara M., van der A D.L., Sera F., Amiano P., Balkau B., Barricarte A., Boeing H., Crowe F.L., Dahm C.C., Dalmeijer G., de Lauzon- Guillain B., Egeberg R., Fagherazzi G., Franks P.W., Krogh V., Huerta J.M., Jakszyn P., Khaw K.T., Li K., Mattiello A., Nilsson P.M., Overvad K., Ricceri F., Rodríguez-Suárez L., Rolandsson O., Sánchez M.J., Slimani N., Sluijs I., Spijkerman A.M.W., Teucher B., Tjonneland A., Tumino R., van den Berg S.W., Forouhi N.G., et al.Association between dietary meat consumption and incident type 2 diabetes: The EPIC-InterAct study.
Diabetologia 2013; 56: 47-59
[IF 6.487]
46
Benetou V., Orfanos P., Pettersson-Kymmer U., Bergström U., Svensson O., Johansson I., Berrino F., Tumino R., Borch K.B., Lund E., Peeters P.H.M., Grote V., Li K., Altzibar J.M., Key T., Boeing H., Von Ruesten A., Norat T., Wark P.A., Riboli E., Trichopoulou A.Mediterranean diet and incidence of hip fractures in a European cohort.
Osteoporos Int 2013; 24: 1587-1598
[IF 4.039]
47
Beretta G.L., Gatti L., Perego P., Zaffaroni N. Camptothecin resistance in cancer: Insights into the molecular mechanisms of a DNA-damaging drug.Curr Med Chem 2013; 20: 1541-1565
N°
Authors
Title
Journal
IF
48
Berger M., Fagioli F., Abate M., Riccardi R., Prete A., Cozza R., Bertulli R., Podda M., Ferrari S., Luksch R.Unusual sites of Ewing sarcoma (ES): A retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG).
Eur J Cancer 2013;